Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Surgical Oncology Clinics of North America|March 11, 2017
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y Ku
Hematology/Oncology Clinics of North America|March 6, 2019
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y Ku
Translational Gastroenterology and Hepatology|October 19, 2020
Next generation sequencing in gastric or gastroesophageal adenocarcinomaGeoffrey Y Ku
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophageal cancer: chemotherapyGeoffrey Y Ku
Surgical Oncology Clinics of North America|March 11, 2017
Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction CancersGeoffrey Y Ku
Oncology (Williston Park, N.Y.)|March 14, 2019
Current Treatment of Esophageal Cancer and Promising Clinical Trials UnderwayGeoffrey Y Ku
Journal of Thoracic Disease|October 22, 2019
Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogicalMegan Greally, Geoffrey Y Ku
Journal of Thoracic Disease|February 13, 2019
Immune checkpoint inhibitors in esophagogastric adenocarcinoma: do the results justify the hype?Megan Greally, Geoffrey Y Ku
Expert Opinion on Emerging Drugs|December 9, 2014
Emerging mAbs for the treatment of esophagogastric cancerGeoffrey Y Ku, David H Ilson
Gastroenterology Clinics of North America|March 31, 2009
Preoperative therapy for esophageal cancerGeoffrey Y Ku, David H Ilson
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Surgical Oncology Clinics of North America|March 11, 2017
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y Ku
Hematology/Oncology Clinics of North America|March 6, 2019
The Current Status of Immunotherapies in Esophagogastric CancerGeoffrey Y Ku
Translational Gastroenterology and Hepatology|October 19, 2020
Next generation sequencing in gastric or gastroesophageal adenocarcinomaGeoffrey Y Ku
Chinese Clinical Oncology|November 14, 2017
Systemic therapy for esophageal cancer: chemotherapyGeoffrey Y Ku
Surgical Oncology Clinics of North America|March 11, 2017
Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction CancersGeoffrey Y Ku
Oncology (Williston Park, N.Y.)|March 14, 2019
Current Treatment of Esophageal Cancer and Promising Clinical Trials UnderwayGeoffrey Y Ku
Journal of Thoracic Disease|October 22, 2019
Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogicalMegan Greally, Geoffrey Y Ku
Journal of Thoracic Disease|February 13, 2019
Immune checkpoint inhibitors in esophagogastric adenocarcinoma: do the results justify the hype?Megan Greally, Geoffrey Y Ku
Expert Opinion on Emerging Drugs|December 9, 2014
Emerging mAbs for the treatment of esophagogastric cancerGeoffrey Y Ku, David H Ilson
Gastroenterology Clinics of North America|March 31, 2009
Preoperative therapy for esophageal cancerGeoffrey Y Ku, David H Ilson
Pageof 11